Stryker Q1 FY26: where the revenue came from and where it went
The whole income statement of Stryker for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jan 1 – Mar 31, 2026
- Reported
- May 11, 2026
Revenue$6.02B
+3% year over year
Gross profit$3.81B
63% margin
Operating profit$0.94B
16% margin
Net profit$0.75B
12% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 6.02 | 100% | +3% |
| Med surg & neurotechnology | 3.21 | 53% | +5% |
| Orthopaedics & spine | 2.81 | 47% | +0% |
| Cost of revenue | −2.21 | 37% | |
| Gross profit | 3.81 | 63% margin | −1pp |
| R&D | −0.41 | 7% | +0pp |
| SG&A | −2.28 | 38% | −1pp |
| Other | −0.18 | 3% | +0pp |
| Operating profit | 0.94 | 16% margin | +1pp |
| Interest & other costs | −0.09 | ||
| Tax | −0.11 | ||
| Net profit | 0.75 | 12% margin | +1pp |
209 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest